This study was undertaken to assess the rate of HPV infection in cervical carcinoma among southern Iranian patients. 101 archival cervical carcinoma tissue samples of a 10 year period were studied for the presence ofHPV DNA in southern Iran by a polymerase chain reaction method. In addition, the presence of high risk HPV-16 and HPV-18 genotypes was investigated. In total, 88 (87.1%) of the samples were HPV DNA positive, of which 83 were squamous cell carcinomas and 5 were adeno-
Introduction
Cervical cancer is the second most prevalent cancer among women worldwide. l However, the prevalence of cervical cancer in Iran is much lower than in the other parts of the world. In 1998, cervical cancer with the prevalence rate of 0.71 per 100000 of population ranked the 14 th common cancer in Fars province, Iran. 2 There is a huge number of publications addressing human papilloma virus (HPV) as the major risk factor of developing cervical cancer. 3 . 4 The E6 and E7 proteins of the virus are known to interfere with cell cycle regulators. S In addition, integration of viral genome into the host DNA results in E6 and E7 protein overexpression which inactivate p53 and retinoblastoma proteins of host cells. s .
B These events collectively result in immortalization of cells and uncontrolled cell proliferation.
Several high risk strains of HPV are known to be more associated with cervical cancer among which, HPV-16 carcinomas. HPV-16 genotype was detected in 26.7% of HPV positive cervical carcinomas; however, none of the samples were positive for the existence of HPV-18 genotype. Collectively, these results suggest that HPV-16 and HPV-18 are not the frequent high risk HPV types in our patients and circulating HPV types in southern Iranian population are different from many other populations. (Pathology Oncology Research Vol 9, No 2,  121-125,2003) and HPV-18 are the most common reported genotypes. According to the International Agency for Research on Cancer (rARC). these two HPV types are classified as carcinogens in humans. 7 It is also reported that HPV-16 integration is significantly associated with invasiveness of genital tumors. 8 The other known risk factors of cervical cancer are high parity, smoking, sexual behavior and hygiene, which are known to modify the risk in women infected with HPV 9 - ll It is estimated that 80% of new cases occur in developing countries. l The incidence of cervical cancer in developed countries is much less than in developing countries which seems to be related to the screening programs in the developed world. It is suggested that biennial screening for HPV combined with Pap tests can have life saving benefits compared to Pap smears alone. l2 Despite the observed close association between HPV-16/18 genotypes and cervical cancer, these two HPV types are not always the most common genotypes among HPV-infected women and/or patients with cervical cancer. 13 Previous studies have postulated that HPV genotypes may vary according to the geographic region. 13 Therefore, having information on the circulating genotypes of HPV and knowing the high risk HPV types in each population will help to perform such screening tests more efficiently. types in a touch down polymerase chain reaction (PCR). Approximately 0.25 pg of extracted DNA was amplified in each 25 pI PCR reaction containing 200 mM of each dNTPs (Boehringer, Germany), 1 U of Taq DNA polymerase (Sinagen, Iran), 2.5pl of lOX PCR buffer, 20 pmol of each primer (TIB MOLBIOL, Germany). The reaction mixture was first heated at 94°C for 4 min and amplification was done for 40 cycles using a touch down PCR program. For the first 7 steps annealing temperature was reduced 2 degrees every 2 cycles from 54°C to 42°C. Further 26 cycles were done at annealing temperature equal to 40°C for 1 min. The denaturation and extension in all cycles were done for 1 min each at 94°c and 72°C, respectively. The products were then overextended for further 5 min at 72°C and kept at 4°C until further use. The amplified fragments were resolved by electrophoresis on the 2% agarose gel in 80 volts for 90 min and stained with ethidiurn bromide and visualized on a UV. transilluminator (Uvitec, UK).
DNA samples positive for HPV DNA were selected for a further amplification with two pairs of type-specific primers to unique sequences of the E6 regions of HPV-16 and HPV-18 as described by Samoylova et al. 15 The primer sequences were as follows: 
HPV DNA detection
To our best knowledge there is no official report on the rate of HPV infection among Iranian patients with cervical carcinoma. Therefore, this study was undertaken to assess the rate of HPV infection and its high risk genotypes in Southern Iranian patients with cervical cancer.
DNA was extracted from paraffin-embedded cervical tissues as follows: 10 pm thick dry sections were sliced from each samples and placed in sterile 2 ml Eppendorf tubes. To avoid carry-over of samples the microtome blade was carefully cleaned with xylene between sectioning of blocks. Paraffin was removed with two rounds of warm xylene extraction (60°C) followed by two 90% ethanol washes. After high-speed centrifugation of the tissues, samples were incubated in digestion buffer (10 mM Tris-CI, pH=8.5, 25 mM EDTA, 0.5% SDS and 2 mg/ml Proteinase K) for 5 days at room temperature with shaking. An equal volume of phenol: chloroform (1: 1) was then added, mixed gently and centrifuged. The aqueous phase was mixed with an equal volume of chloroform. DNA was extracted from aqueous phase by adding an equal volume of isopropanol in the presence of 30 pI of 3 M Na-acetate (pH=5.2). The precipitated DNA was washed twice with 70% ethanol to remove salt. The pellets were vacuum-dried for 15 min and redissolved in deionized distilled water.
A total of 101 formalin-fixed paraffin-embedded blocks of patients with histologically proven cervical cancer obtained from archival specimens of Pathology Department, Shiraz University of Medical Sciences during a 10 years period (1991-2000) were included in this study. Mean age of patients was found to be 49.1 years. Table 1 illustrates the characteristics of tumors. There was no complete information available about parity and smoking status of patients. pmol of each primers (a mixture of HPV-16 and HPV-18 specific primers). 20 ng of HPV DNA as positive control, or 500 ng of extracted DNA from a healthy individual as negative control, or 500 ng of extracted DNA from each samples was added to the reaction mixture. After holding at 94°C for 3 min the mixture was subjected to 30 cycles of PCR amplification (denaturation at 94°C for 1 min, annealing at 58°C for 1 min, and extension at 72°C for 1 min). The last cycle was followed by an additional 5 min of extension at 72°C. The amplified fragments were resolved by electrophoresis on the 2% agarose gel in 80 volts for 90 min and stained with ethidium bromide and visualized on a Uv. transilluminator (Uvitec, UK).
Results

Tissue specimens
In this study 101 tissue samples with confirmed histopathological characteristics of cervical cancer were studied. According to the FICO classification, 93 (92.1%) out of 101 samples were squamous cell carcinomas and 8 (7.9%) out of 101 were diagnosed as adenocarcinomas. Of the 93 squamous cell carcinomas, 16 (17.2%) were carcinoma in situ (CIN) and 77 (82.8%) were invasive carcinomas.
HPV prevalence and genotyping
In total, 88 (85.1 %) out of 101 samples were revealed to be positive for the existence of the specific band amplified by common HPV primers in the PCR (Figure 1 
Discussion
Human papillomavirus is a DNA virus, and its association with cervical cancer is strongly suggested. Certain types of the virus are considered as high risk types due to the great odds ratios of association with cervical cancer and their ability to integrate into the host genome. 16 In the present study we investigated the rate of HPV infection among southern Iranian cervical cancer patients and the frequency of two HPV high risk types in these patients. In total, 87.1 % of studied samples were positive for the presence of HPV DNA, which was comparable with the results of some previous studies in Danish, Belgian, Brazilian and Chinese patients. 17-20 Cenotyping for HPV-16 and HPV-18 revealed that 26.7% of HPV positive samples were HPV-16 DNA positive, however, none of them were positive for HPV-18 DNA. The very low rate of HPV-16 infection in cervical cancer is contrary to the previous reports of high infection rate of this high risk type in different populations ( Table 2) and HLA-DQB1 *0602 alleles in our population.
Of the total 101 tested and 86 HPV positive samples, none were positive for HPV-18 DNA. This is contrary to the high rate of HPV-18 detection in Australia, Senegal and Hong_Kong.
18 ,20,21 HPV-18 is mostly found in adenocarcinoma of cervix and has a low rate in squamous cell carcinoma of cervix.
,28
Since only 8 (7.9%) of 101 samples in this study were adenocarcinomas' it is logical to assume that not having HPV-18 genotype is due to the low adenocarcinoma case numbers. However, it can also suggest that other HPV high risk genotypes are the dominant types in our patients.
In conclusion, our study, which is the first report on the HPV types in Iranian cervical cancer patients, suggests that HPV high risk types among southern Iranian population are different from most other countries. Currently the circulating HPV types in our population are under investigation. 24 In a previous report on the frequency of HLA class II alleles in a limited number of cervical cancer patients, we observed an association between HLA DQB1 *0601 and Squamous Cell Carcinoma of cervix.
25
In that study only one of our patients and none of the controls had DRB1 *1501-DQB1 *0601/0602 haplotype.
In addition, the frequencies of HLA-DRB 1*1501 and HLA-DQB1 *0602 were 6.0% and 8.5%, respectively in southern Iranian normal population. In addition, the frequency of DRB1 *1501-DQB1 *0602 haplotype is 2.5% in southern Iranian normal individuals. 26 The low rate of HPV-16 infection in our cervical cancer patients is consistent with the low frequencies of HLA-DRB1 *1501
